−91.9
Relmada Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−104
FY23:
−51.7
FY24:
−51.8
FY25:
−45.8
Change from FY21 to FY25
millions USD
FY21:
−54.1
FY22:
19.7
FY23:
50.5
FY24:
51.6
FY25:
−48.1
Change from FY21 to FY25
millions USD
FY21:
188
FY22:
45.0
FY23:
−0.10
FY24:
−0.04
FY25:
93.6
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−45.8
All amounts in millions USD